… oligonucleotides for severe genetic diseases through our innovation unit.” Financial Highlights At June 30, 2016, … preclinical development of QR-110 and progress of our innovation programs such as QR-313 for epidermolysis bullosa, …
… focuses on identifying transformational and disruptive innovations across the biopharmaceutical and medical … and commercialization activities. Gerard Platenburg, Chief Innovation Officer at ProQR, will join Yarrow’s board of … focuses on identifying transformational and disruptive innovations across the biopharmaceutical and medical …
… progress in all of our programs as well as in our innovation efforts. Our QR-010 program for CF has completed … from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …